0001237899-13-000025.txt : 20130508
0001237899-13-000025.hdr.sgml : 20130508
20130508174909
ACCESSION NUMBER: 0001237899-13-000025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130506
FILED AS OF DATE: 20130508
DATE AS OF CHANGE: 20130508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YANCOPOULOS GEORGE
CENTRAL INDEX KEY: 0001226690
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 13825841
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-05-06
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001226690
YANCOPOULOS GEORGE
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
1
0
0
President Regeneron Laboratori
Common Stock
2013-05-06
4
M
0
192308.0
13.0
A
1309638
D
Common Stock
2013-05-06
4
F
0
9599.0
260.44
D
1300039
D
Common Stock
2013-05-06
4
F
0
93644.0
260.44
D
1206395
D
Common Stock
2013-05-07
4
S
0
13457.0
261.66
D
1192938
D
Common Stock
2013-05-07
4
S
0
47876.0
262.43
D
1145062
D
Common Stock
2013-05-07
4
S
0
38267.0
263.22
D
1106795
D
Common Stock
2013-05-07
4
S
0
400.0
264.21
D
1106395
D
Common Stock
5591
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
13.0
2013-05-06
4
M
0
192308.0
D
2013-12-15
Common Stock
192308
0
D
Non-Qualified Stock Option (right to buy)
260.44
2013-05-06
4
A
0
9599.0
A
2013-11-06
2013-12-15
Common Stock
9599
9599
D
Represents volume-weighted average price of sales of 13,457 shares of Company stock on May 7, 2013 at prices ranging from $261.50 to $261.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2013 at each separate price.
Represents volume-weighted average price of sales of 47,876 shares of Company stock on May 7, 2013 at prices ranging from $262.00 to $262.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2013 at each separate price.
Represents volume-weighted average price of sales of 38,267 shares of Company stock on May 7, 2013 at prices ranging from $263.00 to $263.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2013 at each separate price.
Represents volume-weighted average price of sales of 400 shares of Company stock on May 7, 2013 at prices ranging from $264.06 to $264.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2013 at each separate price.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
/s/**George D. Yancopoulos
2013-05-08